secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2024-02-13T23:59:59+00:00
Accession:  0001213900-24-012876
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Onconetix appoints Ajit Singh and Thomas Meier to board of directors
--------------------------------------------------------------------

- Ajit Singh, PhD, appointed to fill vacancy created by Neil Campbell's resignation, effective Feb 8, 2024.
- Thomas Meier, PhD, also appointed; press release announced Feb 13, 2024.
- Singh is partner at Artiman Ventures, former CEO of Biolmagene (acquired by Roche), ex-global CEO of Siemens Oncology.
- Meier is co-founder of Santhera Pharmaceuticals, raised ~$300M, managed Raxone approval in Europe.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390024012876/0001213900-24-012876-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390024012876/ea193550-8k_onconetix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-012876

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer